Identification and hit-to-lead optimization of a novel class of CB1 antagonists

Jeffrey J Letourneau, Patrick Jokiel, John Olson, Christopher M Riviello, Koc-Kan Ho, Lihong McAleer, Jingchun Yang, Robert N Swanson, James Baker, Phillip Cowley, Darren Edwards, Nick Ward, Michael H J Ohlmeyer, Maria L Webb

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The discovery, synthesis and preliminary structure-activity relationships (SARs) of a novel class of CB1 antagonists is described. Initial optimization of benzimidazole-based screening hit 4 led to the identification of 'inverted' indole-based lead compound 18c with improved properties versus compound 4 including reduced AlogP, improved microsomal stability and improved aqueous solubility. Compound 18c demonstrates in vivo CB1 antagonist efficacy (CB1 agonist induced hypothermia model) and is orally bioavailable in rat.

LanguageEnglish
Pages5449-5453
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number18
DOIs
Publication statusPublished - 15 Sep 2010

Fingerprint

Hypothermia
Lead compounds
Induced Hypothermia
Structure-Activity Relationship
Solubility
Rats
Screening
benzimidazole
indole
Lead

Keywords

  • animals
  • benzimidazoles
  • humans
  • hypothermia
  • indoles
  • mice
  • microsomes, liver
  • obesity
  • rats
  • rats, wistar
  • receptor, Cannabinoid, CB1
  • solubility
  • structure-activity relationships

Cite this

Letourneau, J. J., Jokiel, P., Olson, J., Riviello, C. M., Ho, K-K., McAleer, L., ... Webb, M. L. (2010). Identification and hit-to-lead optimization of a novel class of CB1 antagonists. Bioorganic and Medicinal Chemistry Letters, 20(18), 5449-5453. https://doi.org/10.1016/j.bmcl.2010.07.091
Letourneau, Jeffrey J ; Jokiel, Patrick ; Olson, John ; Riviello, Christopher M ; Ho, Koc-Kan ; McAleer, Lihong ; Yang, Jingchun ; Swanson, Robert N ; Baker, James ; Cowley, Phillip ; Edwards, Darren ; Ward, Nick ; Ohlmeyer, Michael H J ; Webb, Maria L. / Identification and hit-to-lead optimization of a novel class of CB1 antagonists. In: Bioorganic and Medicinal Chemistry Letters. 2010 ; Vol. 20, No. 18. pp. 5449-5453.
@article{a451ff70a48642bdaf06504e9aacd798,
title = "Identification and hit-to-lead optimization of a novel class of CB1 antagonists",
abstract = "The discovery, synthesis and preliminary structure-activity relationships (SARs) of a novel class of CB1 antagonists is described. Initial optimization of benzimidazole-based screening hit 4 led to the identification of 'inverted' indole-based lead compound 18c with improved properties versus compound 4 including reduced AlogP, improved microsomal stability and improved aqueous solubility. Compound 18c demonstrates in vivo CB1 antagonist efficacy (CB1 agonist induced hypothermia model) and is orally bioavailable in rat.",
keywords = "animals, benzimidazoles, humans, hypothermia, indoles, mice, microsomes, liver, obesity, rats, rats, wistar, receptor, Cannabinoid, CB1, solubility, structure-activity relationships",
author = "Letourneau, {Jeffrey J} and Patrick Jokiel and John Olson and Riviello, {Christopher M} and Koc-Kan Ho and Lihong McAleer and Jingchun Yang and Swanson, {Robert N} and James Baker and Phillip Cowley and Darren Edwards and Nick Ward and Ohlmeyer, {Michael H J} and Webb, {Maria L}",
year = "2010",
month = "9",
day = "15",
doi = "10.1016/j.bmcl.2010.07.091",
language = "English",
volume = "20",
pages = "5449--5453",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
number = "18",

}

Letourneau, JJ, Jokiel, P, Olson, J, Riviello, CM, Ho, K-K, McAleer, L, Yang, J, Swanson, RN, Baker, J, Cowley, P, Edwards, D, Ward, N, Ohlmeyer, MHJ & Webb, ML 2010, 'Identification and hit-to-lead optimization of a novel class of CB1 antagonists' Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 18, pp. 5449-5453. https://doi.org/10.1016/j.bmcl.2010.07.091

Identification and hit-to-lead optimization of a novel class of CB1 antagonists. / Letourneau, Jeffrey J; Jokiel, Patrick; Olson, John; Riviello, Christopher M; Ho, Koc-Kan; McAleer, Lihong; Yang, Jingchun; Swanson, Robert N; Baker, James; Cowley, Phillip; Edwards, Darren; Ward, Nick; Ohlmeyer, Michael H J; Webb, Maria L.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 20, No. 18, 15.09.2010, p. 5449-5453.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification and hit-to-lead optimization of a novel class of CB1 antagonists

AU - Letourneau, Jeffrey J

AU - Jokiel, Patrick

AU - Olson, John

AU - Riviello, Christopher M

AU - Ho, Koc-Kan

AU - McAleer, Lihong

AU - Yang, Jingchun

AU - Swanson, Robert N

AU - Baker, James

AU - Cowley, Phillip

AU - Edwards, Darren

AU - Ward, Nick

AU - Ohlmeyer, Michael H J

AU - Webb, Maria L

PY - 2010/9/15

Y1 - 2010/9/15

N2 - The discovery, synthesis and preliminary structure-activity relationships (SARs) of a novel class of CB1 antagonists is described. Initial optimization of benzimidazole-based screening hit 4 led to the identification of 'inverted' indole-based lead compound 18c with improved properties versus compound 4 including reduced AlogP, improved microsomal stability and improved aqueous solubility. Compound 18c demonstrates in vivo CB1 antagonist efficacy (CB1 agonist induced hypothermia model) and is orally bioavailable in rat.

AB - The discovery, synthesis and preliminary structure-activity relationships (SARs) of a novel class of CB1 antagonists is described. Initial optimization of benzimidazole-based screening hit 4 led to the identification of 'inverted' indole-based lead compound 18c with improved properties versus compound 4 including reduced AlogP, improved microsomal stability and improved aqueous solubility. Compound 18c demonstrates in vivo CB1 antagonist efficacy (CB1 agonist induced hypothermia model) and is orally bioavailable in rat.

KW - animals

KW - benzimidazoles

KW - humans

KW - hypothermia

KW - indoles

KW - mice

KW - microsomes, liver

KW - obesity

KW - rats

KW - rats, wistar

KW - receptor, Cannabinoid, CB1

KW - solubility

KW - structure-activity relationships

UR - http://www.journals.elsevier.com/bioorganic-and-medicinal-chemistry-letters

U2 - 10.1016/j.bmcl.2010.07.091

DO - 10.1016/j.bmcl.2010.07.091

M3 - Article

VL - 20

SP - 5449

EP - 5453

JO - Bioorganic and Medicinal Chemistry Letters

T2 - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 18

ER -